Literature DB >> 36105499

Maximizing patient benefit through a reversed pathway from specialist to generalist: the case of chronic pain.

Ioannis Karageorgiou1, Stamatios Kokkinakis1, Neofytos Maliotis1, Christos Lionis2, Emmanouil K Symvoulakis2.   

Abstract

Polymyalgia Rheumatica (PMR) is a syndrome characterized by chronic pain and/or stiffness in the neck, shoulders or upper arms and hips. It affects adult patients usually over 50 years old and is treated with low-dose oral corticosteroids. In this case, a 68-year-old female with a history of PMR, diagnosed by a specialist sporadically seen in the past, presented to a primary care physician due to herpes zoster (HZ) infection. Thorough history taking, along with a careful review of previous laboratory results, raised serious doubts concerning her diagnosis (PMR). Because the patient described diffuse pain throughout her body, sleep disturbances and a depressed emotional state, fibromyalgia was suspected instead and appropriate treatment was given. The patient remained free of symptoms and corticosteroids for almost a year. Information from this case may help to point out that PMR is a disorder that can be easily confused with other chronic pain conditions with similar manifestations, especially when the initial diagnosis is sped up in terms of consultation depth and care continuity. Under certain circumstances, primary care can lead to improved clinical outcomes.

Entities:  

Keywords:  fibromyalgia; herpes Zoster; polymyalgia rheumatica; primary health care

Year:  2021        PMID: 36105499      PMCID: PMC9389878          DOI: 10.15386/mpr-1873

Source DB:  PubMed          Journal:  Med Pharm Rep        ISSN: 2602-0807


  19 in total

Review 1.  What you can do for your fibromyalgia patient.

Authors:  Carmen E Gota
Journal:  Cleve Clin J Med       Date:  2018-05       Impact factor: 2.321

2.  The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

Authors:  Cynthia S Crowson; Eric L Matteson; Elena Myasoedova; Clement J Michet; Floranne C Ernste; Kenneth J Warrington; John M Davis; Gene G Hunder; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-03

3.  Continuity of care in primary care and association with survival in older people: a 17-year prospective cohort study.

Authors:  Otto R Maarsingh; Ykeda Henry; Peter M van de Ven; Dorly Jh Deeg
Journal:  Br J Gen Pract       Date:  2016-06-20       Impact factor: 5.386

4.  Pitfalls in diagnosing geriatric general pain: coexistence of polymyalgia rheumatism and fibromyalgia.

Authors:  Yu Yokota; Hirofumi Namiki
Journal:  BMJ Case Rep       Date:  2019-07-23

5.  Epidemiology of Polymyalgia Rheumatica 2000-2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population-Based Study.

Authors:  Shafay Raheel; Izzat Shbeeb; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-07-10       Impact factor: 4.794

Review 6.  Polymyalgia Rheumatica.

Authors:  Eric L Matteson; Christian Dejaco
Journal:  Ann Intern Med       Date:  2017-05-02       Impact factor: 25.391

Review 7.  AAPT Diagnostic Criteria for Fibromyalgia.

Authors:  Lesley M Arnold; Robert M Bennett; Leslie J Crofford; Linda E Dean; Daniel J Clauw; Don L Goldenberg; Mary-Ann Fitzcharles; Eduardo S Paiva; Roland Staud; Piercarlo Sarzi-Puttini; Dan Buskila; Gary J Macfarlane
Journal:  J Pain       Date:  2018-11-16       Impact factor: 5.820

Review 8.  Fibromyalgia.

Authors:  Janice E Sumpton; Dwight E Moulin
Journal:  Handb Clin Neurol       Date:  2014

Review 9.  Cognitive behavioural therapies for fibromyalgia.

Authors:  Kathrin Bernardy; Petra Klose; Angela J Busch; Ernest H S Choy; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2013-09-10

Review 10.  Effectiveness of Therapeutic Exercise in Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  M Dolores Sosa-Reina; Susana Nunez-Nagy; Tomás Gallego-Izquierdo; Daniel Pecos-Martín; Jorge Monserrat; Melchor Álvarez-Mon
Journal:  Biomed Res Int       Date:  2017-09-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.